StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CannaPharmaRx's operating cash flow for the twelve months ending Sep 30, 2026 was $523.77K. For fiscal 2025 it was -$789.10K. The highest annual figure on record is $0 in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$789.10K–
FY2024Dec 31, 2024-$1.70M–
FY2023Dec 31, 2023-$2.27M–
FY2022Dec 31, 2022-$1.45M–
FY2021Dec 31, 2021-$2.41M–
FY2020Dec 31, 2020-$563.57K–
FY2019Dec 31, 2019-$3.79M–
FY2018Dec 31, 2018-$941.14K–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016-$22.38K–
FY2015Dec 31, 2015-$2.55M–
FY2014Dec 31, 2014-$1.54M–
FY2013Dec 31, 2013-$11.02K–
FY2012Dec 31, 2012-$10.91K–
FY2011Dec 31, 2011-$12.10K–
FY2010Dec 31, 2010$0–
FY2009Dec 31, 2009-$69.12K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$166.65K–
Q2 FY2026Jun 30, 2026-$127.37K–
Q1 FY2026Mar 31, 2026-$243.66K–
Q4 FY2025Dec 31, 2025$1.06M–
Q3 FY2025Sep 30, 2025-$802.70K–
Q2 FY2025Jun 30, 2025-$446.46K–
Q1 FY2025Mar 31, 2025-$601.38K–
Q4 FY2024Dec 31, 2024-$179.89K–
Q3 FY2024Sep 30, 2024-$540.90K-536.6%
Q2 FY2024Jun 30, 2024-$427.62K–
Q1 FY2024Mar 31, 2024-$548.83K–
Q4 FY2023Dec 31, 2023-$1.30M–
Q3 FY2023Sep 30, 2023$123.88K-62.3%
Q2 FY2023Jun 30, 2023-$482.17K–
Q1 FY2023Mar 31, 2023-$611.74K–
Q4 FY2022Dec 31, 2022-$1.09M–
Q3 FY2022Sep 30, 2022$328.33K–
Q2 FY2022Jun 30, 2022-$310.04K–
Q1 FY2022Mar 31, 2022-$375.18K–
Q4 FY2021Dec 31, 2021-$327.29K-221.8%
Q3 FY2021Sep 30, 2021-$1.03M–
Q2 FY2021Jun 30, 2021-$256.45K–
Q1 FY2021Mar 31, 2021-$799.25K–
Q4 FY2020Dec 31, 2020$268.75K–
Q3 FY2020Sep 30, 2020-$158.97K–
Q2 FY2020Jun 30, 2020-$307.68K–
Q1 FY2020Mar 31, 2020-$365.68K–
Q4 FY2019Dec 31, 2019-$973.38K–
Q3 FY2019Sep 30, 2019-$2.34M–
Q2 FY2019Jun 30, 2019-$309.86K–
Q1 FY2019Mar 31, 2019-$176.52K–
Q4 FY2018Dec 31, 2018-$734.89K–
Q3 FY2018Sep 30, 2018-$168.46K–
Q2 FY2018Jun 30, 2018-$37.78K–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016-$1–

More CannaPharmaRx figures

See a number that looks wrong?